ITI Pharma and Healthcare Fund Regular vs Nippon India Pharma Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹227 Cr | ₹8114 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.35 | 1.82 |
| Manager | Rohan Korde | Sailesh Raj Bhan |
| ISIN Code | INF00XX01BL5 | INF204K01968 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | 3.4% | 3.21% |
| 6 Month | 4.39% | 5.11% |
| 1 Year | -2.96% | 0.8% |
| 3 Year | 18.57% | 20.65% |
| 5 Year | - | 18.3% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | 1.79% | 1.5% |
| 1 Year | 4.26% | 7.15% |
| 3 Year | 17.98% | 18.93% |
| 5 Year | - | 17.25% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 18.94% | 16.99% |
| 3 Year | 20.21% | 20.8% |
| 5 Year | - | 20.54% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | 15.64% | 15.24% |
| Sharp | 0.77% | 0.90% |
| Beta | 0.95% | 0.91% |
| Alpha | -2.74% | -0.55% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Rohan Korde | Sailesh Raj Bhan |
| Total AUM | ₹4626 Cr | ₹96086 Cr |
| Funds Managed | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 3.56 | 1.52 |
| Large Cap | 29.45 | 33.27 |
| Mid Cap | 37.33 | 33.86 |
| Small Cap | 29.66 | 31.35 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.52 | 0.53 |
| Healthcare | 91.78 | 99.47 |
| Basic Materials | 3.67 | - |
| Industrials | 1.86 | - |
| Financial Services | 1.17 | - |
Top Comparisons
PGIM India Corporate Bond Fund - Growth
3Y Returns7.3%
UTI Corporate Bond Fund - Regular Plan - Growth Option
3Y Returns7.71%
Mirae Asset Corporate Bond Fund Regular Growth
3Y Returns7.4%
HSBC Corporate Bond Fund - Regular Growth
3Y Returns7.89%
Mahindra Manulife Multi Cap Fund - Regular Plan - Growth
3Y Returns19.75%
Canara Robeco Multi Cap Fund - Regular (G)
3Y Returns0%
Kotak Infrastructure & Economic Reform Fund - Standard Plan-Growth
3Y Returns21.96%
Tata Infrastructure Fund-Regular Plan- Growth Option
3Y Returns19.04%